Cytarabine Injection Shortage

• • Fresenius Kabi had cytarabine on shortage due to a manufacturing delay.
  • Meitheal Pharmaceuticals had cytarabine on shortage due to a manufacturing delay.
  • Mylan Institutional has discontinued cytarabine presentations.
  • Pfizer had cytarabine on shortage due to increased demand.

• • Cytarabine solution for injection, Fresenius Kabi, 100 mg/mL, 20 mL preservative-free vial, 1 count, NDC 63323-0120-20
  • Cytarabine solution for injection, Meitheal Pharmaceuticals, 100 mg/mL, 20 mL preservative-free vial, 1 count, NDC 71288-0109-20
  • Cytarabine solution for injection, Pfizer, 100 mg/mL, 20 mL preservative-free vial, 1 count, NDC 61703-0319-22
  • Cytarabine solution for injection, Pfizer, 20 mg/mL, 25 mL multiple dose vial, 1 count, NDC 61703-0304-36
  • Cytarabine solution for injection, Pfizer, 20 mg/mL, 5 mL preservative-free vial, 5 count, NDC 61703-0305-38
  • Cytarabine solution for injection, Pfizer, 20 mg/mL, 50 mL preservative-free vial, 1 count, NDC 61703-0303-46

Estimated Resupply Dates

• • All presentations are available.